8-K ·Filed Oct 5, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Monitor the investor presentation on the company's website for any pipeline updates or strategic commentary that could move the stock. This filing itself is non-material.
Latest settled — T+5d
MBRX ▼ -13.16% at T+5d
NEUTRAL call -13.16% · α vs SPY -13.58% · entry $0.4766 → $0.4139
T+1d
Pending
due 20d ago
T+5d
-13.16%
call -13.16% · α -13.58%
$0.4139
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Moleculin Biotech filed an 8-K on October 5, 2026, to furnish an investor presentation (Exhibit 99.1) posted on its website. The filing is a routine Regulation FD disclosure with no new financial data, guidance, or material corporate events.
Key Facts
- Filed on October 5, 2026 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
- Exhibit 99.1 is an investor presentation posted on the company's website.
- No financial results, guidance, or material agreements were disclosed in the filing.
Financial Impact
No financial figures disclosed; presentation content not extractable from filing text.
Risk Factors
- No material information provided; stock may be driven by other upcoming catalysts or news.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-031978 |
| Document: mbrx20260928c_8k.htm | 0001437749-26-031978 |
| Document: 0001437749-26-031978-index-headers.html | 0001437749-26-031978 |
| Document: 0001437749-26-031978-index.html | 0001437749-26-031978 |
| Document: 0001437749-26-031978.txt | 0001437749-26-031978 |
30 reports for MBRX
46% Hit rate @ T+20 Went positive at some point 9 of 16 best @ T+60▲ +78.91%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $6.19 | awaiting T+20 | — | $7.09 (+14.46%) |
Oct 16, 2026 10d ago | 8-K | $0.2804 | awaiting T+20 | — | $7.09 (+2426.75%) |
Oct 9, 2026 16d ago | 8-K | $0.4139 | awaiting T+20 | — | $7.09 (+1611.77%) |
Oct 5, 2026 21d ago | 8-K | $0.4766 | awaiting T+20 | — | $7.09 (+1386.57%) |
Sep 29, 2026 27d ago | 8-K | $0.5264 | awaiting T+20 | — | $7.09 (+1245.93%) |
Sep 29, 2026 27d ago | Press Release | $0.5264 | awaiting T+20 | — | $7.09 (+1245.93%) |
Sep 28, 2026 28d ago | 8-K | $0.5690 | awaiting T+20 | — | $7.09 (+1145.17%) |
Sep 25, 2026 4w ago | 8-K | $0.6016 $6.50 | ▲ +980.45% | ▲ +981.93% | $7.09 (+1077.69%) |
Sep 23, 2026 4w ago | 8-K | $0.5279 $6.31 | ▲ +1095.30% | ▲ +1094.61% | $7.09 (+1242.11%) |
Sep 18, 2026 5w ago | 8-K | $0.5202 | awaiting T+20 | — | $7.09 (−1261.98%) |
Showing 10 of 30
US Market Status
Market Closed — Opens Tue (16h 38m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers